Fig. 7From: Baseline and recurrent exposure to the standard dose of artemisinin-based combination therapies (ACTs) induces oxidative stress and liver damage in mice (BALB/c)Liver Histology section (× 400; H & E) of mice treated with distilled water (control), artemether/lumefantrine (A/L), and artesunate/amodiaquine (A/A) after the (C) third and (D) sixth periods. Congestion of blood vessels (arrow) and degeneration of hepatocytes (bent arrow)Back to article page